Related Experiment Video
Updated: Jun 25, 2026

Bacterial Delivery of RNAi Effectors: Transkingdom RNAi
Published on: August 18, 2010
Small hairpin RNA targeting at Bcl-2 increases cytarabine-induced apoptosis in Raji cells
1Institute of Hematology, Medical College of Jinan University, Guangzhou, China. thedm@jnu.edu.cn
Abstract:
Bcl-2, a prominent member of the Bcl-2 family proteins, is responsible for the dysregulation of apoptosis and resistance to chemotherapy. In this study, we investigated whether small hairpin RNA (shRNA) targeting at Bcl-2 mRNA could enhance cytarabine (Ara-C)-induced apoptosis in Raji cells. Bcl-2 shRNA was transfected into Raji cells and the expression levels of Bcl-2 mRNA and protein were assayed by RT-PCR and immunofluorescence. Cell proliferation was determined by MTT assay. Apoptosis was determined by morphological observation and flow cytometric analysis. Our results show that expression levels of Bcl-2 mRNA and protein from Raji cells transfected with Bcl-2 shRNA decreased, compared with either negative control shRNA group or untransfected cells group (P < 0.05). Viability of cells transfected with Bcl-2 shRNA was less than the cells transfected with control shRNA and untransfected Raji cells, respectively (P < 0.05). Bcl-2 shRNA combined with Ara-C significantly inhibited the growth of cells (P < 0.05). There was no difference in cell survival between control shRNA/Ara-C combination and cells treated with Ara-C alone. Using Giemsa staining, cells treated with Bcl-2 shRNA plus Ara-C at 48 h displayed changes of apoptosis. Apoptotic rates of Raji cells treated with Bcl-2 shRNA combined with Ara-C significantly increased (P < 0.05), compared with either control shRNA/Ara-C combination or Ara-C-treated cells alone. Our results suggest that the shRNA against Bcl-2 mRNA could increase Ara-C-induced apoptosis in Raji cells.
Insights
Small hairpin RNA (shRNA) targeting Bcl-2 mRNA effectively reduced Bcl-2 expression in Raji cells. This approach enhanced cytarabine (Ara-C)-induced apoptosis, offering a potential strategy to overcome chemotherapy resistance.
Area of Science:
- Molecular Biology
- Cancer Research
- RNA Interference
Background:
- Bcl-2 protein dysregulates apoptosis and promotes chemotherapy resistance in cancer cells.
- Targeting Bcl-2 is a strategy to enhance cancer treatment efficacy.
Purpose of the Study:
- To investigate if small hairpin RNA (shRNA) targeting Bcl-2 mRNA can enhance cytarabine (Ara-C)-induced apoptosis in Raji cells.
- To assess the impact of Bcl-2 shRNA on cell proliferation and apoptosis when combined with Ara-C.
Main Methods:
- Transfection of Raji cells with Bcl-2 shRNA.
- Assay of Bcl-2 mRNA and protein expression using RT-PCR and immunofluorescence.
- Evaluation of cell proliferation via MTT assay.
- Determination of apoptosis through morphological observation and flow cytometry.
Main Results:
- Bcl-2 shRNA significantly decreased Bcl-2 mRNA and protein levels in Raji cells.
- Cells transfected with Bcl-2 shRNA exhibited reduced viability.
- Combination of Bcl-2 shRNA and Ara-C significantly inhibited cell growth and increased apoptosis rates compared to Ara-C alone.
Conclusions:
- shRNA targeting Bcl-2 mRNA is effective in reducing Bcl-2 expression in Raji cells.
- Bcl-2 shRNA potentiates Ara-C-induced apoptosis, suggesting a therapeutic potential for overcoming chemoresistance.
Related Concept Videos
Experimental RNAi
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
The Intrinsic Apoptotic Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Inhibition of Cdk Activity
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...